Similar articles for PMID: 21547131

Year	Number of Results
2003	1
2006	3
2007	9
2008	12
2009	14
2010	9
2011	20
2012	21
2013	9
2014	16
2015	7
2016	5
2017	8
2018	4
2019	8
2020	4
2021	11
2022	14
2023	11
2024	0

1

Sunitinib for Taiwanese patients with gastrointestinal stromal tumor after imatinib treatment failure or intolerance.

Chen YY, Yeh CN, Cheng CT, Chen TW, Rau KM, Jan YY, Chen MF. Chen YY, et al. World J Gastroenterol. 2011 Apr 28;17(16):2113-9. doi: 10.3748/wjg.v17.i16.2113. World J Gastroenterol. 2011. PMID: 21547131 Free PMC article.

2

Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor.

Heinrich MC, Maki RG, Corless CL, Antonescu CR, Harlow A, Griffith D, Town A, McKinley A, Ou WB, Fletcher JA, Fletcher CD, Huang X, Cohen DP, Baum CM, Demetri GD. Heinrich MC, et al. J Clin Oncol. 2008 Nov 20;26(33):5352-9. doi: 10.1200/JCO.2007.15.7461. Epub 2008 Oct 27. J Clin Oncol. 2008. PMID: 18955458 Free PMC article. Clinical Trial.

3

Imatinib escalation or sunitinib treatment after first-line imatinib in metastatic gastrointestinal stromal tumor patients.

Hsu CC, Wu CE, Chen JS, Tseng JH, Chiang KC, Liu YY, Tsai CY, Cheng CT, Chen TW, Jan YY, Yeh TS, Chen YY, Yeh CN. Hsu CC, et al. Anticancer Res. 2014 Sep;34(9):5029-36. Anticancer Res. 2014. PMID: 25202087

4

Sunitinib as a second-line therapy for advanced GISTs after failure of imatinib: relationship between efficacy and tumor genotype in Korean patients.

Yoon DH, Ryu MH, Ryoo BY, Beck M, Choi DR, Cho Y, Lee JL, Chang HM, Kim TW, Kang YK. Yoon DH, et al. Invest New Drugs. 2012 Apr;30(2):819-27. doi: 10.1007/s10637-010-9593-1. Epub 2010 Nov 23. Invest New Drugs. 2012. PMID: 21104107

5

Kinase mutations and imatinib mesylate response for 64 Taiwanese with advanced GIST: preliminary experience from Chang Gung Memorial Hospital.

Yeh CN, Chen TW, Lee HL, Liu YY, Chao TC, Hwang TL, Jan YY, Chen MF. Yeh CN, et al. Ann Surg Oncol. 2007 Mar;14(3):1123-8. doi: 10.1245/s10434-006-9288-1. Epub 2006 Dec 31. Ann Surg Oncol. 2007. PMID: 17195905 Clinical Trial.

6

[Clinicopathological features and prognosis of gastrointestinal stromal tumors with KIT/PDGFRA gene "homozygous mutation": a multicenter retrospective cohort study].

Shen YY, Li XQ, Yang LX, Fang Y, Nie MM, He ZR, Hou YY, Cao H, Wang M, Shen KT. Shen YY, et al. Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Sep 25;24(9):804-813. doi: 10.3760/cma.j.cn.441530-20210720-00293. Zhonghua Wei Chang Wai Ke Za Zhi. 2021. PMID: 34530562 Chinese.

7

The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study.

Rutkowski P, Bylina E, Klimczak A, Switaj T, Falkowski S, Kroc J, Lugowska I, Brzeskwiniewicz M, Melerowicz W, Osuch C, Mierzejewska E, Wasielewski K, Woźniak A, Grzesiakowska U, Nowecki ZI, Siedlecki JA, Limon J. Rutkowski P, et al. BMC Cancer. 2012 Mar 22;12:107. doi: 10.1186/1471-2407-12-107. BMC Cancer. 2012. PMID: 22439647 Free PMC article.

8

Correlation of KIT and PDGFRA mutational status with clinical benefit in patients with gastrointestinal stromal tumor treated with sunitinib in a worldwide treatment-use trial.

Reichardt P, Demetri GD, Gelderblom H, Rutkowski P, Im SA, Gupta S, Kang YK, Schöffski P, Schuette J, Soulières D, Blay JY, Goldstein D, Fly K, Huang X, Corsaro M, Lechuga MJ, Martini JF, Heinrich MC. Reichardt P, et al. BMC Cancer. 2016 Jan 15;16:22. doi: 10.1186/s12885-016-2051-5. BMC Cancer. 2016. PMID: 26772734 Free PMC article. Clinical Trial.

9

[Secondary mutation of c-kit/PDGFRα genotypes after imatinib mesylate therapy and its relationship with efficacy of sunitinib].

Hong JL, Li J, Li J, Shen L. Hong JL, et al. Zhonghua Bing Li Xue Za Zhi. 2012 Jun;41(6):386-90. doi: 10.3760/cma.j.issn.0529-5807.2012.06.006. Zhonghua Bing Li Xue Za Zhi. 2012. PMID: 22932406 Chinese.

10

[Efficacy and safety of sunitinib on patients with imatinib-resistant gastrointestinal stromal tumor].

Liu X, Jiang WZ, Guan GX, Chen ZF, Chi P, Lu HS. Liu X, et al. Zhonghua Wei Chang Wai Ke Za Zhi. 2013 Mar;16(3):221-5. Zhonghua Wei Chang Wai Ke Za Zhi. 2013. PMID: 23536339 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

166 results

Results by year